AK

Alok Kumar

Active Director Director DIN 08537382
DIN 08537382 First appointment Aug 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Alok Kumar

Data last updated:

Alok Kumar is a Director at Kmedlan Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Kmedlan Pharmaceuticals Private Limited reported revenue of ₹10.9 Lakh (FY 2022).

DIN 08537382
Primary Designation Director
Industry Chemicals
First Appointment 14 Aug 2019
Oldest Company Age 7 yrs
Largest company Kmedlan Pharmaceuticals Private Limited · ₹10.9 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Aug 20192019₹10.9 Lakh (FY 2022)Active

Board colleagues of Alok Kumar

NameDINCompanyDesignation
Avanish Kumar08537381Kmedlan Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kmedlan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Alok Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alok Kumar

Alok Kumar currently holds 1 directorship: Kmedlan Pharmaceuticals Private Limited (Director, since 14 Aug 2019, revenue ₹10.9 Lakh (FY 2022)).

Alok Kumar was first appointed on 14 Aug 2019 as Director at Kmedlan Pharmaceuticals Private Limited.

The current boards of Alok Kumar's companies include Avanish Kumar (Kmedlan Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available